Formulation Strategies for ‘First-Into-Man’ Studies The ‘first-into-man’ stage of a clinical trial for any new drug always has a
high failure rate. As a result, ensuring the supporting formulation platform
for the API is suitable is a key task, as Robert Harris at Molecular Profiles
points out. Robert Harris (September 2011)
Keywords: The ‘first-into-man’ stage of a clinical trial for any new drug always has a
high failure rate. As a result, ensuring the supporting formulation platform
for the API is suitable is a key task, as Robert Harris at Molecular Profiles
points out.
|
